Influence of transcatheter arterial chemoembolization on the prognosis after hepatectomy for hepatocellular carcinoma in patients with severe liver dysfunction

Anticancer Research

Volumn 26, Issue 5 B, 2006, Pages 3685-3692

  Kaibori, Masaki ^a   Tanigawa, Noboru ^a   Matsui, Yoichi ^a   Saito, Takamichi ^a   Uchida, Yoichiro ^a   Ishizaki, Morihiko ^a   Tanaka, Hironori ^a   Kamiyama, Yasuo ^a  

^a KANSAI MEDICAL UNIVERSITY HOSPITAL   (Japan)

Author keywords

Hepatectomy; Hepatocellular carcinoma; Prognosis; Transcatheter arterial chemoembolization

Indexed keywords

EPIRUBICIN; INDOCYANINE GREEN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; LIVER DYSFUNCTION; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

AGED; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; COMBINED MODALITY THERAPY; FEMALE; HEPATECTOMY; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RECURRENCE; SURVIVAL ANALYSIS;

EID: 33750682312     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Fan ST, Lo CM, Liu CL et al: Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg 229: 322-330, 1999.
2. Tung-Ping Poon R, Fan ST and Wong J: Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 252: 10-24, 2000.
3. Tsai TJ, Chau GY, Lui WY et al: Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma. Surgery 79: 1501-1508, 1997.
4. Imamura H, Matsuyama Y, Tanaka E et al: Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 38: 200-207, 2003.
5. Poon RT, Fan ST, Ng IO et al: Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer 89: 500-507, 2000.
6. Nakamura H, Tanaka T, Hori S et al: Transcatheter embolization of hepatocellular carcinoma: assessment of efficacy in cases of resection following embolization. Radiology 147: 401-405, 1983.
7. Sakurai M, Okamura J and Kuroda C: Transcatheter chemoembolization effective for treating hepatocellular carcinoma. A histopathologic study. Cancer 54: 387-392, 1984.
8. Harada T, Matsuo K, Inoue T et al: Is preoperative hepatic arterial chemoembolization safe and effective for hepatocellular carcinoma? Ann Surg 224: 4-9, 1996.
9. Lu CD, Peng SY, Jiang XC et al: Preoperative transcatheter arterial chemoembolization and prognosis of patients with hepatocellular carcinomas: retrospective analysis of 120 cases. World J Surg 23: 293-300, 1999.
10. Sugo H, Futagawa S, Beppu T et al: Role of preoperative transcatheter arterial chemoembolization for respectable hepatocellular carcinoma: relation between postoperative course and the pattern of tumor recurrence. World J Surg 27: 1295-1299, 2003.
11. Majno P, Adam R, Bismuth H et al: Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 226: 688-703, 1997.
12. Uchida M, Kohno H, Kubota H et al: Role of preoperative transcatheter arterial oily chemoembolization for resectable heptocellular carcinoma. World J Surg 20: 326-331, 1996.
13. Yamasaki S, Hasegawa H, Kinoshita H et al: A prospective randomized trial of the preventive effect of pre-operative transcatheter arterial embolization against recurrence of hepatocellular carcinoma. Jpn J Cancer Res 87: 206-211, 1996.
14. Nagasue N, Kohno H, Tachibana M et al: Prognostic factors after hepatic resection for hepatocellular carcinoma associated with Child-Turcotte class B and C cirrhosis. Ann Surg 229: 84-90, 1999.
15. Kaibori M, Matsui Y, Kitade H et al: Hepatic resection for hepatocellular carcinoma in severely cirrhotic livers. Hepatogastroenterology 50: 491-496, 2003.
16. Kaibori M, Matsui Y, Yanagida H et al: Positive status of alpha-fetoprotein and des-gamma-carboxy prothrombin: important prognostic factor for recurrent hepatocellular carcinoma. World J Surg 28: 702-707, 2004.
17. Makuuchi M, Kosuge T, Takayama T et al: Surgery for small liver cancers. Semin Surg Oncol 9: 298-304, 1993.
18. Imamura H, Sano K, Sugawara Y et al: Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test. J Hepatobiliary Pancreat Surg 12: 16-22, 2005.
19. Couinaud C: Les hepatectomies elargies. In: Le Foie: Etudes Anatomiques et Chirurgicales. Couinaud C (ed.) Paris: Masson pp. 400-409, 1957.
20. Sobin LH, Wittekind C (eds.): TNM Classification of Malignant Tumours. 5th ed. New York: Wiley, 1997.
21. Yamada R, Sato M, Kawabata M et al: Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 148: 397-401, 1983.
22. Sato Y, Fujiwara K, Ogata I et al: Transcatheter arterial embolization for hepatocellular carcinoma: benefits and limitations for unresectable cases with liver cirrhosis evaluated by comparison with other conservative treatments. Cancer 55: 2822-2825, 1985.
23. Adachi E, Matsumata T, Nishizaki T et al: Effects of preoperative transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma. The relationship between postoperative course and tumor necrosis. Cancer 72: 3593-3598, 1993.
24. Matsui O, Kadoya M, Yoshikawa J et al: Small hepatocellular carcinoma: treatment with subsegmental transcatheter arterial embolization. Radiology 188: 79-83, 1993.